4,639
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Formulation and in vitro/in vivo evaluation of chitosan-based film forming gel containing ketoprofen

ORCID Icon, , , , , , , , , , & show all
Pages 1056-1066 | Received 26 Apr 2017, Accepted 20 Jun 2017, Published online: 07 Jul 2017

References

  • Ahmed TA, Khalid M. (2014). Development of alginate-reinforced chitosan nanoparticles utilizing W/O nanoemulsification/internal crosslinking technique for transdermal delivery of rabeprazole. Life Sci 110:35–43.
  • Ashraf S, Mapp PI, Walsh DA. (2011). Contributions of angiogenesis to inflammation, joint damage, and pain in a rat model of osteoarthritis. Arthritis Rheum 63:2700–10.
  • Bu W, Chen Z, Chen F, Shi J. (2009). Oleic acid/oleylamine cooperative-controlled crystallization mechanism for monodisperse tetragonal bipyramid NaLa (MoO4) 2 nanocrystals. J Phys Chem C 113:12176–85.
  • Cho J-R, Van Duong A, Nguyen LTT, Chi S-C. (2016). Design of transdermal matrix patch containing ondansetron. J Pharm Investig 46:677–84.
  • Cialdai C, Giuliani S, Valenti C, et al. (2009). Effect of Intra-articular 4-(S)-Amino-5-(4-{4-[2, 4-dichloro-3-(2, 4-dimethyl-8-quinolyloxymethyl) phenylsulfonamido]-tetrahydro-2H-4-pyranylcarbonyl} piperazino)-5-oxopentyl](trimethyl) ammonium chloride hydrochloride (MEN16132), a Kinin B2 Receptor Antagonist, on Nociceptive Response in Monosodium Iodoacetate-Induced Experimental Osteoarthritis in Rats. J Pharmacol Exp Ther 331:1025–32.
  • Cordero J, Alarcon L, Escribano E, et al. (1997). A comparative study of the transdermal penetration of a series of nonsteroidal antiinflammatory drugs. J Pharm Sci 86:503–8.
  • Domard A, Domard M. (2001). Chitosan: structure-properties relationship and biomedical applications. Polym Biomater 2:187–212.
  • El-Say KM, Ahmed TA, Badr-Eldin SM, et al. (2015). Enhanced permeation parameters of optimized nanostructured simvastatin transdermal films: ex vivo and in vivo evaluation. Pharm Dev Technol 20:919–26.
  • El Fray M, Niemczyk A, Pabin-Szafko B. (2012). Chemical modification of chitosan with fatty acids. Prog Chem Appl Chitin Deriv 17:29–36.
  • Fabra M, Talens P, Chiralt A. (2010). Water sorption isotherms and phase transitions of sodium caseinate–lipid films as affected by lipid interactions. Food Hydrocolloids 24:384–91.
  • Fernihough J, Gentry C, Malcangio M, et al. (2004). Pain related behaviour in two models of osteoarthritis in the rat knee. Pain 112:83–93.
  • Hurler J, Engesland A, Poorahmary Kermany B, Škalko‐Basnet N. (2012). Improved texture analysis for hydrogel characterization: gel cohesiveness, adhesiveness, and hardness. J Appl Polym Sci 125:180–8.
  • Kantor TG. (1986). Ketoprofen: a review of its pharmacologic and clinical properties. Pharmacotherapy 6:93–102.
  • Kim CK, Kim J-J, Chi S-C, Shim C-K. (1993). Effect of fatty acids and urea on the penetration of ketoprofen through rat skin. Int J Pharm 99:109–18.
  • Kim J-H, Choi H-K. (2002). Effect of additives on the crystallization and the permeation of ketoprofen from adhesive matrix. Int J Pharm 236:81–5.
  • Koosha M, Mirzadeh H, Shokrgozar MA, Farokhi M. (2015). Nanoclay-reinforced electrospun chitosan/PVA nanocomposite nanofibers for biomedical applications. RSC Adv 5:10479–87.
  • Li P, Zhu AM, Liu QL, Zhang QG. (2008). Fe3O4/poly (N-isopropylacrylamide)/chitosan composite microspheres with multiresponsive properties. Ind Eng Chem Res 47:7700–6.
  • Li X, Zhang R, Liang R, et al. (2014). Preparation and characterization of sustained-release rotigotine film-forming gel. Int J Pharm 460:273–9.
  • Lipp R, Müller-Fahrnow A. (1999). Use of X-ray crystallography for the characterization of single crystals grown in steroid containing transdermal drug delivery systems. Eur J Pharm Biopharm 47:133–8.
  • Ma X, Taw J, Chiang C-M. (1996). Control of drug crystallization in transdermal matrix system. Int J Pharm 142:115–19.
  • Magari K, Miyata S, Ohkubo Y, et al. (2003). Calcineurin inhibitors exert rapid reduction of inflammatory pain in rat adjuvant‐induced arthritis. Br J Pharmacol 139:927–34.
  • Mundada A, Satturwar P, Fulzele S, et al. (2011). Characterization and evaluation of novel film forming polymer for drug delivery. Iran J Pharm Res 10:35.
  • Naik A, Pechtold LA, Potts RO, Guy RH. (1995). Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans. J Control Release 37:299–306.
  • Nascimento T, Calado V, Carvalho C. (2012). Development and characterization of flexible film based on starch and passion fruit mesocarp flour with nanoparticles. Food Res Int 49:588–95.
  • Nicoli S, Penna E, Padula C, et al. (2006). New transdermal bioadhesive film containing oxybutynin: in vitro permeation across rabbit ear skin. Int J Pharm 325:2–7.
  • No HK, Park NY, Lee SH, Meyers SP. (2002). Antibacterial activity of chitosans and chitosan oligomers with different molecular weights. Int J Food Microbiol 74:65–72.
  • Ongpipattanakul B, Burnette RR, Potts RO, Francoeur ML. (1991). Evidence that oleic acid exists in a separate phase within stratum corneum lipids. Pharm Res 8:350–4.
  • Padula C, Colombo G, Nicoli S, et al. (2003). Bioadhesive film for the transdermal delivery of lidocaine: in vitro and in vivo behavior. J Control Release 88:277–85.
  • Park CW, Ma KW, Jang SW, et al. (2014). Comparison of Piroxicam Pharmacokinetics and anti-inflammatory effect in rats after Intra-articular and intramuscular administration. Biomol Ther 22:260.
  • Patel RK, Leswell PF. General Practice Study Group. (1996). Comparison of ketoprofen, piroxicam, and diclofenac gels in the treatment of acute soft-tissue injury in general practice. Clin Ther 18:497–507.
  • Rhee Y-S, Chang S-Y, Park C-W, et al. (2008). Optimization of ibuprofen gel formulations using experimental design technique for enhanced transdermal penetration. Int J Pharm 364:14–20.
  • Richardson CJ, Blocka KL, Ross SG, Verbeeck RK. (1985). Effects of age and sex on piroxicam disposition. Clin Pharmacol Ther 37:13–18.
  • Ruhi G, Modi O, Dhawan S. (2015). Chitosan-polypyrrole-SiO 2 composite coatings with advanced anticorrosive properties. Synthetic Metals 200:24–39.
  • Shinde A, Garala K, More H. (2008). Development and characterization of transdermal therapeutics system of tramadol hydrochloride. Asian J Pharm 2:265.
  • Touitou E, Godin B, Karl Y, et al. (2002). Oleic acid, a skin penetration enhancer, affects Langerhans cells and corneocytes. J Control Release 80:1–7.
  • Vane JR. (1971). Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 231:232–5.
  • Vargas M, Albors A, Chiralt A, González-Martínez C. (2009). Characterization of chitosan–oleic acid composite films. Food Hydrocolloids 23:536–47.
  • Walker RB, Smith EW. (1996). The role of percutaneous penetration enhancers. Adv Drug Deliv Rev 18:295–301.
  • Williams AC, Barry BW. (2012). Penetration enhancers. Adv Drug Deliv Rev 64:128–37.
  • Yahya M, Arof A. (2003). Effect of oleic acid plasticizer on chitosan–lithium acetate solid polymer electrolytes. Eur Polym J 39:897–902.
  • Yoshimi E, Kumakura F, Hatori C, et al. (2010). Antinociceptive effects of AS1892802, a novel Rho kinase inhibitor, in rat models of inflammatory and noninflammatory arthritis. J Pharmacol Exp Ther 334:955–63.